Quest Diagnostics Reveals Planned Senior Notes Offering For $500M

Quest Diagnostics Inc DGX revealed that it plans to offer $500 million aggregate principal amount of senior notes in a public offering. The company indicated that the issuance of the notes would be subject to customary closing conditions.

Related Link: Chardan Initiates Asterias Biotherapeutics At Buy On Potential Cell Therapy Competitiveness

Quest Diagnostics said that it would plan to use the net proceeds from the offering to repay outstanding indebtedness under its senior unsecured revolving credit facility, as well as, its secured receivables credit facility and for general corporate purposes.

Goldman Sachs, Mizuho Securities and Wells Fargo are slated to be joint book-running managers for the debt offering. The company said that its base prospectus for the offering could be obtained from Goldman.

At time of writing, Quest Diagnostics was down 0.58 percent at $76.07.